198 related articles for article (PubMed ID: 33766555)
1. Application of chemoresistive gas sensors and chemometric analysis to differentiate the fingerprints of global volatile organic compounds from diseases. Preliminary results of COPD, lung cancer and breast cancer.
Rodríguez-Aguilar M; Díaz de León-Martínez L; Gorocica-Rosete P; Pérez-Padilla R; Domínguez-Reyes CA; Tenorio-Torres JA; Ornelas-Rebolledo O; Mehta G; Zamora-Mendoza BN; Flores-Ramírez R
Clin Chim Acta; 2021 Jul; 518():83-92. PubMed ID: 33766555
[TBL] [Abstract][Full Text] [Related]
2. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
3. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
4. Determination of global chemical patterns in exhaled breath for the discrimination of lung damage in postCOVID patients using olfactory technology.
Zamora-Mendoza BN; Sandoval-Flores H; Rodríguez-Aguilar M; Jiménez-González C; Alcántara-Quintana LE; Berumen-Rodríguez AA; Flores-Ramírez R
Talanta; 2023 May; 256():124299. PubMed ID: 36696734
[TBL] [Abstract][Full Text] [Related]
5. Detection of COPD and Lung Cancer with electronic nose using ensemble learning methods.
V A B; Subramoniam M; Mathew L
Clin Chim Acta; 2021 Dec; 523():231-238. PubMed ID: 34627826
[TBL] [Abstract][Full Text] [Related]
6. Identification of volatile organic compounds in the urine of patients with cervical cancer. Test concept for timely screening.
Díaz de León-Martínez L; Flores-Ramírez R; López-Mendoza CM; Rodríguez-Aguilar M; Metha G; Zúñiga-Martínez L; Ornelas-Rebolledo O; Alcántara-Quintana LE
Clin Chim Acta; 2021 Nov; 522():132-140. PubMed ID: 34418363
[TBL] [Abstract][Full Text] [Related]
7. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
[TBL] [Abstract][Full Text] [Related]
9. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study.
Díaz de León-Martínez L; Rodríguez-Aguilar M; Gorocica-Rosete P; Domínguez-Reyes CA; Martínez-Bustos V; Tenorio-Torres JA; Ornelas-Rebolledo O; Cruz-Ramos JA; Balderas-Segura B; Flores-Ramírez R
J Breath Res; 2020 Sep; 14(4):046009. PubMed ID: 32698165
[TBL] [Abstract][Full Text] [Related]
10. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
11. Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
Zamora-Mendoza BN; Díaz de León-Martínez L; Rodríguez-Aguilar M; Mizaikoff B; Flores-Ramírez R
Talanta; 2022 Jan; 236():122832. PubMed ID: 34635222
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of COPD and lung cancer from controls through breath analysis using a self-developed e-nose.
Binson VA; Subramoniam M; Mathew L
J Breath Res; 2021 Aug; 15(4):. PubMed ID: 34243176
[TBL] [Abstract][Full Text] [Related]
13. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
[TBL] [Abstract][Full Text] [Related]
14. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
15. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose.
V A B; Subramoniam M; Mathew L
Expert Rev Mol Diagn; 2021 Nov; 21(11):1223-1233. PubMed ID: 34415806
[TBL] [Abstract][Full Text] [Related]
17. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
18. Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study.
van Velzen P; Brinkman P; Knobel HH; van den Berg JWK; Jonkers RE; Loijmans RJ; Prins JM; Sterk PJ
COPD; 2019 Dec; 16(5-6):330-337. PubMed ID: 31588813
[TBL] [Abstract][Full Text] [Related]
19. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
[TBL] [Abstract][Full Text] [Related]
20. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]